Mar. 3 at 11:59 AM
$SOPH Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of -
$0.28 down -21.74% YoY
• Reported revenue of
$21.71M up 22.41% YoY
• SOPHIA GENETICS anticipates FY 2026 revenue between
$92M and
$94M, growing 20% to 22% year-over-year, with an adjusted EBITDA loss of
$29M to
$32M. The company expects to reach adjusted EBITDA breakeven by the end of 2026.
